
Metwise ER 50 Tablet
Marketer
Medwise Pharmaceuticals
Salt Composition
Metoprolol Succinate (47.5mg)
Overview Metwise ER 50 Tablet
Extended-release metoprolol succinate 50 mg tablets (a beta-blocker) are indicated for hypertension, angina pectoris, and cardiac arrhythmias. This medication also helps prevent migraine recurrence, subsequent myocardial infarctions, and cerebrovascular accidents. Dosage and administration frequency vary depending on the specific indication and disease severity; it may be used alone or in combination with other therapies. Optimal results require consistent daily dosing at the same time, either with or without food. Full therapeutic benefit may take several weeks to manifest, and long-term use is often necessary. Discontinuing treatment may exacerbate the underlying condition. Common, generally transient adverse effects include fatigue, cephalgia, depressive symptoms, diarrhea, dermatological reactions, bradycardia, dizziness, and nausea. Less frequent side effects include dyspnea and hypotension. To minimize adverse events, gradual dose escalation is recommended. Report persistent or bothersome side effects to your physician. Prior to initiating therapy, inform your doctor of any hepatic dysfunction. This medication may be contraindicated in individuals with bradycardia, significant circulatory compromise, decompensated heart failure, or hypotension. Consult your doctor before use during pregnancy or breastfeeding. Individual suitability must be assessed by a healthcare professional. Regular blood pressure monitoring is essential to gauge treatment efficacy. Alcohol consumption should be avoided due to a potential increase in side effects.
Primary Ingredients of Metwise ER 50 Tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of Metwise ER 50 Tablet
Management of angina pectoris|Cardiac arrhythmia management|Mitigation of myocardial infarction risk|Hypertension therapy|Migraine prophylaxis
Major Benefits of Metwise ER 50 Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Metwise ER 50 Tablet whole; avoid chewing, crushing, or breaking it. While it can be taken with or without food, consistent timing is recommended. For optimal absorption, minimize consumption with high-fat foods like olive oil, nuts (including Brazil nuts), dark chocolate, butter, and fatty meats.
Common Side effects of Metwise ER 50 Tablet:
- Tiredness
- Dizziness
- Depression
- Breathlessness
- Headache
- Slow heart rate
- Nausea
- Rash
- Diarrhea
- Hypotension (low blood pressure)
How to use Metwise ER 50 Tablet:
Consume Metwise ER 50 Tablet precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or breaking it. This medication can be taken with or without food, although consistent timing is recommended. For optimal absorption, it's advisable to avoid consumption alongside meals rich in fats, including those containing olive oil, nuts and seeds (like Brazil nuts), dark chocolate, butter, or meat.
How Metwise ER 50 Tablet works:
Extended-release metoprolol succinate (50 mg) tablets are a cardioselective beta-adrenergic blocking agent, reducing heart rate and improving cardiac output.
SAFETY ADVICE
AlcoholUNSAFE
Combining Metwise ER 50 Tablet and alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Extended-release metformin 50 mg tablets may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against the risks before prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Extended-release metformin 50 mg tablets appear to be compatible with breastfeeding. Available human data indicate minimal risk to the infant.
DrivingUNSAFE
Extended-release metformin 50 mg tablets can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
Metformin extended-release 50 mg tablets are considered safe for use in individuals with impaired renal function. No alteration of the Metformin extended-release 50 mg tablet dosage is necessary.
LiverCAUTION
Patients with liver impairment should use Metwise ER 50 Tablets cautiously; dosage modification may be necessary. A physician's consultation is advised.
What if you forget to take Metwise ER 50 Tablet :
Should you forget a Metwise ER 50 Tablet dose, take it immediately. If your next dose is imminent, however, omit the missed dose and resume your usual schedule. Never take a double dose.
Facts to Know About Metwise ER 50 Tablet
| Label | Value |
|---|---|
| Chemical Type | Alcohols and Phenols |
| Developing Habits | No. |
| Treatment Category | Heart |
